Brief: Mereo Biopharma Group Files Prospectus For Offer, Resale By Selling Shareholders Of Up To 26.6 Mln Of Ordinary Shares In Form Of ADSS
25/11/2024 22:17
Nov 25 (Reuters) - Mereo Biopharma Group PLC MAH0y.F :
* MEREO BIOPHARMA GROUP FILES PROSPECTUS FOR OFFER, RESALE
BY
SELLING SHAREHOLDERS OF UP TO 26.6 MILLION OF ORDINARY SHARES IN
FORM OF ADSS
Source text: ID:n0001193125-24-265173
Further company coverage: MAH0y.F
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Mereo BioPharma
See all newsBrief: Sentynl Therapeutics And Mereo Biopharma Announce Option And License Agreement For Alvelestat In Alpha-1 Antitrypsin Deficiency-Associated Lung Disease
UK's Mereo BioPharma Q2 loss narrows on lower R&D spending
Brief: Mereo BioPharma Q2 Operating Income USD -7.03 Million
Brief: Mereo BioPharma Q1 Net Income USD -6.719 Million
Brief: Mereo BioPharma FY Revenue USD 500 Thousand Vs. IBES Estimate USD 520 Thousand